An alternative anti-coronavirus jab aimed at protecting those who cannot receive vaccines will enter major trials this weekend. The drug is made by AstraZeneca , the pharmaceutical company that worked with Oxford University in the UK to develop a general vaccine. The alternative injection was developed using antibodies produced by a single coronavirus patient in the US. The arm jab takes effect immediately and could protect people against transmission for ...